Company intelligence / Profile preview

Shanghai Golden Leaf MedTec

Shanghai/Xuhui District/Juke Biopark, Shanghai, Chinasigma.larvol.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Shanghai Golden Leaf MedTec has completed pivotal clinical trials of its Netrod™ radiofrequency renal denervation system, showing significant blood pressure reduction compared to placebo controls. The product is approved by the NMPA in China, received CE mark in Europe, and FDA Breakthrough Device Designation in the US. Their endovascular denervation device for type 2 diabetes has shown feasibility and safety in early trials but is not yet commercialized.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: DeviceRadiofrequency ablation deviceEndovascular denervation system
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

Netrod

Phase 3

Indications: Uncontrolled hypertension

1 more asset in the full pipeline.

Request access →

Partnerships

Jianxing Medical Fund as investor/funderFosun Health as investor/funderNNFE Fund Management as investor/funderGuangzhou Yiyao Investment as investor/funder

Beyond the preview

Go deeper on Shanghai Golden Leaf MedTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Golden Leaf MedTec.

Explore the full profile